JC
JPMorgan Chase & Co cut its LBRX stake below 5%
JPMorgan Chase & Co reported owning 4.3% of Lb Pharmaceuticals Inc (LBRX) (1,401,790 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 13, 2026
- Source
- Schedule 13G